Functionality of a novel follitropin alfa pen injector: Results from human factor interactions by patients and nurses

Functionality of a novel follitropin alfa pen injector

Helen Saunders, working at Gedeon Richter/PregLem, a Hungarian/Swiss based biopharmaceutical company, has focused her research on the benefits of a novel Follitropin alfa pen injector known as Bemfola®, which uses follicle-stimulating hormone (FSH), a reproductive hormone for the treatment of infertility in women and men. Bemfola® has numerous benefits that make it an exciting alternative to other more complicated treatment […]

Read More…